調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users, and Region(North America, Europe, APAC, Latin America & MEA) - Global Forecast to 2026

世界の除細動器市場予測（～2026）：製品タイプ別、患者別、エンドユーザー別、地域別

◆タイトル：Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users, and Region(North America, Europe, APAC, Latin America & MEA) - Global Forecast to 2026
◆商品コード：MD3124
◆調査・発行会社：MarketsandMarkets
◆発行日：2021年11月25日
◆ページ数：219
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥0見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

マーケッツアンドマーケッツ社は、除細動器の世界市場規模が2021年114億ドルから2026年182億ドルまで、年平均9.7％成長すると予測しています。本調査資料では、世界の除細動器市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、種類別（植込み型除細動器、外部型除細動器）分析、患者別（成人患者、小児患者）分析、エンドユーザー別（病院・クリニック・心臓センター、プレホスピタルケア、公共用、代替医療施設、在宅医療）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・除細動器の世界市場規模：種類別（植込み型除細動器、外部型除細動器）
・除細動器の世界市場規模：患者別（成人患者、小児患者）
・除細動器の世界市場規模：エンドユーザー別（病院・クリニック・心臓センター、プレホスピタルケア、公共用、代替医療施設、在宅医療）
・除細動器の世界市場規模：地域別
・競争状況
・企業情報

“The global defibrillator market is expected to reach USD 18.2 billion by 2026 from an estimated USD 11.4 billion in 2021, at a CAGR of 9.7% from 2021 to 2026.”
Defibrillators are specialized devices that monitor the heart rhythm and deliver electric shocks to rectify abnormal heart rhythms on detection, and as such, play an important role in the treatment of sudden cardiac arrest. Growth in this market is mainly driven by the rising prevalence of target diseases, growing focus on providing public-access defibrillators, and training and awareness programs on defibrillators. In addition, emerging markets and the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to offer growth opportunities for players in the defibrillators market. Cardiovascular disease (CVD) is a leading cause of death and disability across the globe. Globally, 17.9 million deaths due to CVD were reported in 2019, which amounts to 32% of the total deaths worldwide (Source: WHO). More than 75% of deaths due to CVDs occur in low- and middle-income countries. In the US alone, there were more than 390,000 sudden cardiac arrests in 2018 (Source: American Heart Association). Of the total US population, around 65% of deaths due to CVDs occur in people aged 75 and over, 29% in the age group of 55–74, and 6% in the age group of 35–54. Owing to this, the demand for defibrillators has increased, as these devices help save the lives of patients at a high risk of cardiac arrest.
However, issues related to the use of implantable and automated external defibrillators, frequent product recalls, and a lack of awareness about sudden cardiac arrest in developing nations are expected to hinder the growth of the defibrillators market during the forecast period. Other factors such as limited reimbursements, lack of infrastructure, particularly in developing and underdeveloped countries are also expected to hinder the growth of this market.

“Implantable Cardioverter Defibrillator segment accounted for the largest share of global defibrillator market in 2020”
Based on type, the defibrillators market is broadly segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. The ICDs is further divided into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators, whereas external defibrillators are divided into manual aed, fully automated aed and wearable defibrillator. The ICDs segment accounted for a share of 71.5% of the global defibrillators market in 2020. The large share of this market segment can be attributed to the increasing prevalence of cardiovascular diseases and the development of technologically advanced defibrillators. For instance in July 2020, Abbott received FDA approval for its next-generation ICDs and CRT-Ds under the brand name of Gallant.

“Hospitals, clinics and cardiac centres segment accounted for the largest market share of the defibrillator market based on end user in 2020”
Based on end users, the defibrillators market is segmented into hospitals, clinics, and cardiac centers; prehospital care settings; public-access markets; alternate care facilities; home care settings; and other end users. The hospitals, clinics, and cardiac centers segment dominated the global defibrillators market, with a share of 80.2%, in 2020. The development of advanced ICDs and CRT-Ds and the large number of ICD and CRT-D implant procedures performed in hospitals, clinics, and cardiac centers are the major factors contributing to the large share of this end-user segment. The growing number of cardiac implant procedures and the availability of reimbursements across developed markets are the other major factors driving the growth of this end-user segment. According to the American Heart Association, an estimated 10,000 ICD procedures are carried out each month in the US alone (data as of July 2016). Similarly, the total number of ICD implants in England increased to 72 per million population in 2014 from 66 per million population in 2012 (Source: British Heart Rhythm Society).

“Adult patients segment accounted for the largest market share of the defibrillator market based on patients type in 2020”
Based on patient type, the defibrillators market is segmented into adult and pediatric patients. The adult patients segment dominated the global defibrillators market with a share of 59.5% in 2020.
In 2020, there were roughly 75 million adult patients (in the age group of 15 years and over) globally and 25 million pediatric patients (in the age group of 0–14 years) (Source: World Bank). According to data by the World Health Organization (WHO), around 30% of all global deaths occur due to cardiovascular disease, accounting for 17.9 million lives lost each year. About 2 in 10 deaths due to CVD (cardiovascular disease) occur in patients aged less than 65 (Source: Center for Disease Control and Prevention). The major reasons for heart disease are high blood pressure, high cholesterol, diabetes, obesity, unhealthy diets, physical inactivity, and excessive alcohol use.
The development of advanced ICDs, CRT-Ds, and AEDs, along with increasing awareness about cardiac diseases and preventive measures taken by government bodies, are the major factors contributing to the growth of the market.

“The APAC market, by region, to register highest growth rate in the forecast period”
The global defibrillators market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 44.2% of the global defibrillators market, followed by Europe. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. Factors such as the high burden of target diseases, rising geriatric population, and increasing awareness regarding defibrillators support the growth of the defibrillators market in the APAC. Particularly in Japan; increasing disposable incomes, allowing for greater affordability for advanced technologies; the rising prevalence of target diseases; and favorable government initiatives. Such factors help to drive the market in this region and draw foreign investments and partnerships. On the other hand, low hospital budgets, high equipment costs, and a lack of government investments in some countries are limiting the growth of the market in the Asia Pacific to a certain extent.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–25%, Tier 2–37%, and Tier 3– 38%
• By Designation: C-level–34%, Director-level–35%, and Others–31%
• By Region: North America–24%, Europe–32%, Asia Pacific–28%, Latin America–10%, and the Middle East & Africa–6%

Prominent players in the defibrillators market include Medtronic (Ireland), Stryker Corporation (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), Nihon Kohden (Japan) and MicroPort (China).

Research Coverage
This report studies the defibrillator market based on product type, patient type, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
 Market Penetration: Comprehensive information on the product portfolios offered by the top players in the defibrillaotr market
 Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the defibrillator market
 Market Development: Comprehensive information on lucrative emerging regions
 Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the defibrillator market
 Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

【レポートの目次】

1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 29
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 YEARS CONSIDERED FOR THE STUDY 30
1.4 CURRENCY USED FOR THE STUDY 30
1.5 KEY MARKET STAKEHOLDERS 31
1.6 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA SOURCES 33
2.1.1.1 Indicative List of Secondary sources 34
2.1.2 PRIMARY DATA 34
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 35
2.1.2.1 Key industry insights 36
2.2 MARKET SIZE ESTIMATION METHODOLOGY 36
FIGURE 3 REVENUE MAPPING-BASED MARKET ESTIMATION 37
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
2.3 MARKET DATA VALIDATION AND TRIANGULATION 39
FIGURE 5 DATA TRIANGULATION METHODOLOGY 39
2.4 KEY RESEARCH ASSUMPTIONS 40
2.5 LIMITATIONS 40
2.5.1 METHODOLOGY-RELATED LIMITATIONS 40
2.6 RISK ASSESSMENT 41
TABLE 1 RISK ASSESSMENT: DEFIBRILLATORS MARKET 41
2.7 COVID-19 HEALTH ASSESSMENT 41
2.8 COVID-19 ECONOMIC ASSESSMENT 41
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 42
FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY 42
FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021–2022) 43
3 EXECUTIVE SUMMARY 44
FIGURE 8 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 44
FIGURE 9 DEFIBRILLATORS MARKET SHARE, BY END USER, 2020 VS. 2026 45
FIGURE 10 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021 VS. 2026 46
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE DEFIBRILLATORS MARKET 46
4 PREMIUM INSIGHTS 48
4.1 DEFIBRILLATORS MARKET OVERVIEW 48
FIGURE 12 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH 48
4.2 DEFIBRILLATORS MARKET, BY REGION AND END USER, 2020 (USD MILLION) 49
FIGURE 13 HOSPITALS, CLINICS, AND CARDIAC CENTERS TO DOMINATE THE DEFIBRILLATORS MARKET, BY END USER, IN 2020 49
4.3 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 50
FIGURE 14 IMPLANTABLE DEFIBRILLATORS WILL CONTINUE TO DOMINATE THE DEFIBRILLATORS MARKET IN 2026 50
4.4 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET 50
FIGURE 15 ASIA PACIFIC IS THE FASTEST-GROWING MARKET FOR DEFIBRILLATORS 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
FIGURE 16 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
5.2.1 DRIVERS 52
5.2.1.1 Rising prevalence of target diseases 52
FIGURE 17 GERIATRIC POPULATION, BY REGION, 2019 VS. 2030 (THOUSAND) 52
5.2.1.2 Growing focus on providing public-access defibrillators 53
5.2.1.3 Training & awareness programs on defibrillators 53
5.2.2 RESTRAINTS 54
5.2.2.1 Issues related to the use of implantable and automated external defibrillators 54
5.2.3 OPPORTUNITIES 55
5.2.3.1 Emerging markets 55
5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds 55
5.2.4 CHALLENGES 56
5.2.4.1 Frequent product recalls 56
TABLE 2 RECENT PRODUCT RECALLS BY THE US FDA, 2018–2021 56
5.2.4.2 Lack of awareness about sudden cardiac arrest in developing nations 56
5.3 INDUSTRY TRENDS 57
5.3.1 INCREASING PRICING PRESSURE ON MARKET PLAYERS 57
5.3.2 GROWING NUMBER OF MERGERS & ACQUISITIONS AMONG MARKET PLAYERS 57
5.3.3 RISING DEMAND FOR AUTOMATED EXTERNAL DEFIBRILLATORS IN PREHOSPITAL SETTINGS 58
5.4 PRICING ANALYSIS 58
TABLE 3 PRICING ANALYSIS: DEFIBRILLATORS MARKET, 2021 (USD) 58
 
5.5 REGULATORY ANALYSIS 58
TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE DEFIBRILLATORS MARKET 58
5.5.1 NORTH AMERICA 59
5.5.1.1 US 59
TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY THE US FDA 59
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 60
5.5.1.2 Canada 60
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 60
5.5.2 EUROPE 61
5.5.3 ASIA PACIFIC 61
5.5.3.1 Japan 61
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 61
5.5.3.2 China 62
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 62
5.5.3.3 India 63
5.6 VALUE CHAIN ANALYSIS 64
5.6.1 RESEARCH & DEVELOPMENT 64
5.6.2 MANUFACTURING & ASSEMBLY 64
5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 64
FIGURE 18 DEFIBRILLATORS MARKET: VALUE CHAIN ANALYSIS 64
5.7 ECOSYSTEM LANDSCAPE 65
5.8 REIMBURSEMENT SCENARIO 65
TABLE 10 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN THE US 2021 66
5.9 PORTER’S FIVE FORCES ANALYSIS 67
TABLE 11 DEFIBRILLATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 67
5.9.1 THREAT FROM NEW ENTRANTS 67
5.9.2 THREAT FROM SUBSTITUTES 67
5.9.3 BARGAINING POWER OF SUPPLIERS 67
5.9.4 BARGAINING POWER OF BUYERS 68
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 68
5.10 IMPACT OF COVID-19 ON THE DEFIBRILLATORS MARKET 68
5.11 PATENT ANALYSIS 69
5.11.1 PATENTS GRANTED FOR DEFIBRILLATORS 69
FIGURE 19 PATENTS GRANTED FOR DEFIBRILLATORS
(JANUARY 2011 TO SEPTEMBER 2021) 69
5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS 69
TABLE 12 TOP 20 PATENT OWNERS FOR DEFIBRILLATORS
(JANUARY 2011 TO SEPTEMBER 2021) 69
FIGURE 20 TOP 10 PATENT APPLICANTS FOR DEFIBRILLATORS
(JANUARY 2011 TO SEPTEMBER 2021) 70
FIGURE 21 PATENT DOCUMENTS FOR DEFIBRILLATORS, BY JURISDICTION
(JANUARY 2011 TO SEPTEMBER 2021) 71
6 DEFIBRILLATORS MARKET, BY TYPE 72
6.1 INTRODUCTION 73
TABLE 13 DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 73
TABLE 14 DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 73
TABLE 15 DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 74
TABLE 16 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 74
6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 74
TABLE 17 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 75
TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 75
TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 76
TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 76
6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 77
TABLE 21 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2018–2026 (USD MILLION) 77
TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY REGION, 2018–2026 (USD MILLION) 77
6.2.1.1 Biventricular ICDs/cardiac resynchronization therapy defibrillators 78
6.2.1.1.1 Launch of technologically advanced CRT-D devices to support market growth 78
TABLE 23 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 79
6.2.1.2 Dual-chamber ICDs 79
6.2.1.2.1 Dual-chamber ICDs reduce the incidence of inappropriate shocks—a key factor driving market growth 79
TABLE 24 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 80
6.2.1.3 Single-chamber ICDs 80
6.2.1.3.1 Single-chamber ICDs are associated with the increased risk of inappropriate shocks—a key factor limiting market growth 80
TABLE 25 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 81
6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 81
6.2.2.1 S-ICDs segment to register the highest growth in the ICDs market 81
TABLE 26 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 82
6.3 EXTERNAL DEFIBRILLATORS 82
TABLE 27 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 82
TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2018–2026 (USD MILLION) 83
TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY END USER,
2018–2026 (USD MILLION) 83
TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 83
6.3.1 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS 84
6.3.1.1 Development of technologically advanced AEDs negatively affects the market for manual external defibrillators 84
TABLE 31 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET,
BY REGION, 2018–2026 (USD MILLION) 85
6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS 85
6.3.2.1 Increasing installation of these devices in public places to drive market growth 85
TABLE 32 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION,
2018–2026 (USD MILLION) 86
6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS 86
6.3.3.1 Concerns associated with the use of WCDs are expected to hamper their adoption 86
TABLE 33 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION,
2018–2026 (USD MILLION) 87
7 DEFIBRILLATORS MARKET, BY PATIENT TYPE 88
7.1 INTRODUCTION 89
TABLE 34 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 89
7.2 ADULT PATIENTS 89
7.2.1 ADVANCEMENTS IN DEFIBRILLATION TECHNIQUES TO BOOST ADOPTION OF DEFIBRILLATORS AMONG ADULT PATIENTS 89
TABLE 35 DEFIBRILLATORS MARKET FOR ADULT PATIENTS, BY REGION,
2018–2026 (USD MILLION) 90
7.3 PEDIATRIC PATIENTS 90
7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO DRIVE MARKET GROWTH 90
TABLE 36 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2018–2026 (USD MILLION) 91
8 DEFIBRILLATORS MARKET, BY END USER 92
8.1 INTRODUCTION 93
TABLE 37 DEFIBRILLATORS MARKET, BY END USER TYPE, 2018–2026 (USD MILLION) 93
8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS 93
8.2.1 MOST ICD PROCEDURES ARE CARRIED OUT IN HOSPITALS, CLINICS, AND CARDIAC CENTERS—A KEY FACTOR DRIVING MARKET GROWTH 93
TABLE 38 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2018–2026 (USD MILLION) 94
8.3 PREHOSPITAL CARE SETTINGS 94
8.3.1 GROWING FUNDING FOR PREHOSPITAL EMERGENCY AMBULANCE SERVICES IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH 94
TABLE 39 DEFIBRILLATORS MARKET FOR PREHOSPITAL CARE SETTINGS, BY REGION, 2018–2026 (USD MILLION) 95
8.4 PUBLIC-ACCESS MARKETS 95
8.4.1 RISING INCIDENCE OF OUT-OF-HOSPITAL CARDIAC ARRESTS TO DRIVE THE ADOPTION OF DEFIBRILLATORS 95
TABLE 40 DEFIBRILLATORS MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2018–2026 (USD MILLION) 96
8.5 ALTERNATE CARE FACILITIES 96
8.5.1 UNDERDEVELOPED INFRASTRUCTURE FOR ALTERNATE CARE IN MOST EUROPEAN COUNTRIES AND EMERGING NATIONS TO RESTRAIN MARKET GROWTH 96
TABLE 41 DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2018–2026 (USD MILLION) 96
8.6 HOME CARE SETTINGS 97
8.6.1 INCREASING ADOPTION OF HOME AUTOMATED EXTERNAL DEFIBRILLATORS—A KEY FACTOR DRIVING MARKET GROWTH 97
TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION,
2018–2026 (USD MILLION) 97
8.7 OTHER END USERS 98
TABLE 43 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION,
2018–2026 (USD MILLION) 98
9 DEFIBRILLATORS MARKET, BY REGION 99
9.1 INTRODUCTION 100
FIGURE 22 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET 100
TABLE 44 DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 100
9.2 NORTH AMERICA 101
FIGURE 23 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT 101
TABLE 45 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY,
2018–2026 (USD MILLION) 102
TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 102
TABLE 47 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 102
TABLE 48 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 103
TABLE 49 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 103
TABLE 50 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER,
2018–2026 (USD MILLION) 104
TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 104
9.2.1 US 104
9.2.1.1 High adoption rate of AEDs in the country to drive market growth 104
TABLE 52 US: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 106
TABLE 53 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 106
TABLE 54 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 106
TABLE 55 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 107
9.2.2 CANADA 107
9.2.2.1 High burden of CVDs in the country contributes to the growth of the defibrillators market in Canada 107
TABLE 56 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 108
TABLE 57 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 108
TABLE 58 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 108
TABLE 59 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 109
9.3 EUROPE 109
TABLE 60 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY,
2018–2026 (USD MILLION) 109
TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 110
TABLE 62 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 110
TABLE 63 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 110
TABLE 64 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 111
TABLE 65 EUROPE: DEFIBRILLATORS MARKET, BY END USER,
2018–2026 (USD MILLION) 111
TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 112
9.3.1 GERMANY 112
9.3.1.1 Presence of non-profit organizations that provide defibrillator services in the country to drive market growth in Germany 112
TABLE 67 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 113
TABLE 68 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2018–2026 (USD MILLION) 113
TABLE 69 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 113
TABLE 70 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 114
9.3.2 UK 114
9.3.2.1 Rising support from government and private organizations and increasing awareness related to defibrillators are fueling market growth 114
TABLE 71 UK: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 115
TABLE 72 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 115
TABLE 73 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 115
TABLE 74 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 116
9.3.3 FRANCE 116
9.3.3.1 Increasing prevalence of chronic diseases in the geriatric population—a key driver for market growth in France 116
TABLE 75 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 117
TABLE 76 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 117
TABLE 77 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 117
TABLE 78 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 118
9.3.4 ITALY 118
9.3.4.1 High prevalence of OHCA in the country is driving the growth of the defibrillators market in Italy 118
TABLE 79 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 118
TABLE 80 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 119
TABLE 81 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 119
TABLE 82 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 119
9.3.5 SPAIN 120
9.3.5.1 Increasing number of conferences and awareness programs to support the growth of the defibrillators market in Spain 120
TABLE 83 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 120
TABLE 84 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 120
TABLE 85 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 121
TABLE 86 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 121
9.3.6 REST OF EUROPE 121
TABLE 87 ROE: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 122
TABLE 88 ROE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 122
TABLE 89 ROE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 122
TABLE 90 ROE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 123
9.4 ASIA PACIFIC 123
FIGURE 24 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT 124
TABLE 91 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY,
2018–2026 (USD MILLION) 125
TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 125
TABLE 93 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2018–2026 (USD MILLION) 125
TABLE 94 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 126
TABLE 95 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 126
TABLE 96 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER,
2018–2026 (USD MILLION) 127
TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 127
9.4.1 JAPAN 127
9.4.1.1 Presence of a universal insurance scheme in Japan to support market growth 127
TABLE 98 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 128
TABLE 99 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 128
TABLE 100 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 129
TABLE 101 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 129
9.4.2 CHINA 129
9.4.2.1 Growing focus of market players on expanding their presence in China to drive market growth 129
TABLE 102 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 130
TABLE 103 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 130
TABLE 104 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 131
TABLE 105 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 131
9.4.3 INDIA 131
9.4.3.1 High incidence and prevalence of CVDs in the country to drive market growth 131
TABLE 106 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 132
TABLE 107 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 132
TABLE 108 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 133
TABLE 109 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 133
9.4.4 AUSTRALIA 133
9.4.4.1 Measures taken by government and private bodies to make AEDs available at public sites in the country to drive market growth 133
TABLE 110 AUSTRALIA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 134
TABLE 111 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2018–2026 (USD MILLION) 134
TABLE 112 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 134
TABLE 113 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 135
9.4.5 SOUTH KOREA 135
9.4.5.1 Rising incidence of cardiac disorders to drive the growth of the defibrillators market in South Korea 135
TABLE 114 SOUTH KOREA: DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 135
TABLE 115 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET,
BY TYPE, 2018–2026 (USD MILLION) 136
TABLE 116 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 136
TABLE 117 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 136
9.4.6 REST OF ASIA PACIFIC (ROAPAC) 137
TABLE 118 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 137
TABLE 119 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 138
TABLE 120 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 138
TABLE 121 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 138
9.5 LATIN AMERICA 139
TABLE 122 LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY,
2018–2026 (USD MILLION) 139
TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 139
TABLE 124 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 140
TABLE 125 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 140
TABLE 126 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 140
TABLE 127 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER,
2018–2026 (USD MILLION) 141
TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 141
9.5.1 BRAZIL 141
9.5.1.1 Large obese population in the country results in an increased demand for defibrillators 141
TABLE 129 BRAZIL: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 142
TABLE 130 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 142
TABLE 131 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 142
TABLE 132 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 143
9.5.2 MEXICO 143
9.5.2.1 High prevalence of target diseases in the country to drive the growth of the defibrillators market in Mexico 143
TABLE 133 MEXICO: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 143
TABLE 134 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 144
TABLE 135 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 144
TABLE 136 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 144
9.5.3 REST OF LATIN AMERICA 145
TABLE 137 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 145
TABLE 138 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 145
TABLE 139 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 146
TABLE 140 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 146
9.6 MIDDLE EAST & AFRICA 147
TABLE 141 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY TYPE,
2018–2026 (USD MILLION) 147
TABLE 142 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 147
TABLE 143 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 148
TABLE 144 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 148
TABLE 145 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER,
2018–2026 (USD MILLION) 149
TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 149
10 COMPETITIVE LANDSCAPE 150
10.1 INTRODUCTION 150
FIGURE 25 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE DEFIBRILLATORS MARKET, 2018–2021 150
10.2 REVENUE SHARE ANALYSIS 151
FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATORS MARKET 151
10.3 MARKET SHARE ANALYSIS 152
FIGURE 27 DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2020 152
TABLE 147 DEFIBRILLATOR MARKET: DEGREE OF COMPETITION 152
10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020) 154
10.4.1 TERMINOLOGY/NOMENCLATURE 154
10.4.1.1 Stars 154
10.4.1.2 Emerging leaders 154
10.4.1.3 Pervasive players 154
10.4.1.4 Participants 154
FIGURE 28 DEFIBRILLATORS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 155
10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT
(AS OF 2020) 156
10.5.1 PROGRESSIVE COMPANIES 156
10.5.2 RESPONSIVE COMPANIES 156
10.5.3 DYNAMIC COMPANIES 156
10.5.4 STARTING BLOCKS 156
FIGURE 29 DEFIBRILLATORS MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) 157
10.6 COMPETITIVE BENCHMARKING 158
TABLE 148 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATORS MARKET 158
TABLE 149 END-USER FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATOR MARKET 159
TABLE 150 COMPANY FOOTPRINT ANALYSIS IN THE DEFIBRILLATORS MARKET 160
10.7 COMPETITIVE SCENARIO (2018–2021) 161
10.7.1 NEW PRODUCT LAUNCHES & APPROVALS 161
10.7.2 DEALS 162
10.7.3 OTHER DEVELOPMENTS 162
11 COMPANY PROFILES 164
11.1 KEY PLAYERS 164
(Business overview, Products offered, Recent developments, MNM view)*
11.1.1 MEDTRONIC 164
TABLE 151 MEDTRONIC: BUSINESS OVERVIEW 164
FIGURE 30 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 165
11.1.2 STRYKER CORPORATION 169
TABLE 152 STRYKER CORPORATION: BUSINESS OVERVIEW 169
FIGURE 31 STRYKER CORPORATION: COMPANY SNAPSHOT (2020) 170
11.1.3 KONINKLIJKE PHILIPS N.V. 172
TABLE 153 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 172
FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 173
11.1.4 ASAHI KASEI CORPORATION 176
TABLE 154 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 176
FIGURE 33 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2020) 177
11.1.5 BOSTON SCIENTIFIC CORPORATION 179
TABLE 155 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 179
FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 180
11.1.6 ABBOTT 183
TABLE 156 ABBOTT: BUSINESS OVERVIEW 183
FIGURE 35 ABBOTT: COMPANY SNAPSHOT (2020) 184
11.1.7 MICROPORT 186
TABLE 157 MICROPORT: BUSINESS OVERVIEW 186
FIGURE 36 MICROPORT: COMPANY SNAPSHOT (2020) 187
11.1.8 NIHON KOHDEN CORPORATION 189
TABLE 158 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 189
FIGURE 37 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020) 190
11.1.9 BIOTRONIK 192
TABLE 159 BIOTRONIK: BUSINESS OVERVIEW 192
11.1.10 CU MEDICAL SYSTEMS INC. 194
TABLE 160 CU MEDICAL SYSTEMS INC.: BUSINESS OVERVIEW 194
FIGURE 38 CU MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT (2020) 194
11.1.11 METSIS MEDIKAL 196
TABLE 161 METSIS MEDIKAL: BUSINESS OVERVIEW 196
11.1.12 MEDIANA CO. LTD. 197
TABLE 162 MEDIANA CO. LTD.: BUSINESS OVERVIEW 197
FIGURE 39 MEDIANA CO. LTD.: COMPANY SNAPSHOT (2020) 197
11.1.13 MINDRAY MEDICAL INTERNATIONAL LIMITED 199
TABLE 163 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 199
FIGURE 40 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2020) 200
11.1.14 PROGETTI SRL – MEDICAL EQUIPMENT SOLUTIONS 202
TABLE 164 PROGETTI SRL – MEDICAL EQUIPMENT SOLUTIONS: BUSINESS OVERVIEW 202
11.1.15 SCHILLER AG 203
TABLE 165 SCHILLER AG: BUSINESS OVERVIEW 203
11.2 OTHER PLAYERS 205
11.2.1 BPL MEDICAL TECHNOLOGIES 205
TABLE 166 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 205
11.2.2 METRAX GMBH (PRIMEDIC) 206
TABLE 167 METRAX GMBH (PRIMEDIC): BUSINESS OVERVIEW 206
11.2.3 MS WESTFALIA GMBH 207
TABLE 168 MS WESTFALIA GMBH: BUSINESS OVERVIEW 207
11.2.4 BEXEN CARDIO 208
TABLE 169 BEXEN CARDIO: BUSINESS OVERVIEW 208
11.2.5 AXION MEDICAL EQUIPMENT LTD. 210
TABLE 170 AXION MEDICAL EQUIPMENT LTD.: BUSINESS OVERVIEW 210
11.2.6 ELEMENT SCIENCE INC. 211
TABLE 171 ELEMENT SCIENCE INC.: BUSINESS OVERVIEW 211
11.2.7 AVIVE SOLUTIONS INC. 212
TABLE 172 AVIVE SOLUTIONS INC.: BUSINESS OVERVIEW 212
11.2.8 JEEVTRONICS PVT. LTD. 213
TABLE 173 JEEVTRONICS PVT. LTD.: BUSINESS OVERVIEW 213
11.2.9 HEARTHERO INC. 214
TABLE 174 HEARTHERO INC.: BUSINESS OVERVIEW 214
11.2.10 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD. 215
TABLE 175 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW 215
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.

12 APPENDIX 216
12.1 DISCUSSION GUIDE 216
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 220
12.3 AVAILABLE CUSTOMIZATIONS 222
12.4 RELATED REPORTS 223
12.5 AUTHOR DETAILS 224



★調査レポート[世界の除細動器市場予測（～2026）：製品タイプ別、患者別、エンドユーザー別、地域別] ( Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users, and Region(North America, Europe, APAC, Latin America & MEA) - Global Forecast to 2026 / MD3124) 販売に関する免責事項
[世界の除細動器市場予測（～2026）：製品タイプ別、患者別、エンドユーザー別、地域別] ( Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users, and Region(North America, Europe, APAC, Latin America & MEA) - Global Forecast to 2026 / MD3124) についてEメールでお問い合わせ
◆関連調査資料◆
  • 世界の食事代替品市場予測（～2026）：製品タイプ別、流通チャネル別、地域別
    FB1201 / MarketsandMarkets / 2021年12月3日 / マーケッツアンドマーケッツ社は、食事代替品の世界市場規模が2021年119億ドルから2026年155億ドルまで、年平均5.4％成長すると予測しています。本調査資料では、世界の食事代替品市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、製品タイプ別（粉末、レディトゥドリンク、バー、その他）分析、流通チャネル別（オフライン、オンライン）分析、地域別分析、競争状況などの項目を掲載しています。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・食事代替品の世界市場規模：製品タイプ別（粉末、レディトゥドリンク、バー、その他） ・食事代替品の世界市場規模：流通チャネル別（オフライン、オンライン） ・食事代替品の世界市場規模：地域別 ・競争状況...“According to MarketsandMarkets, the global meal replacement market size is estimated to be valued at USD 11.9 billion in 2021 and is projected to reach USD 15.5 billion by 2026, recording a CAGR of 5.4% during the forecast period in terms of value.” The market is primarily driven by factors such as increasing prevalence of obesity and diabetes coupled with the increasing population of health-conscious consumers and changing consumer lifestyle and availability of convenient nutritious meal in the form of meal replacement. However, high cost associated with meal replacement products and presence of unwanted ingredients such as sugar, and artificial...
  • 世界の熱可塑性パイプ市場予測（～2026）：製品タイプ別、ポリマータイプ別、用途別、産業別、地域別
    EP3392 / MarketsandMarkets / 2021年12月6日 / マーケッツアンドマーケッツ社の本調査資料では、熱可塑性パイプの世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品タイプ別（熱可塑性複合パイプ（TCP）、強化熱可塑性パイプ（RTP））分析、ポリマータイプ別（PE、PP、PVDF、PVC、その他）分析、用途別（オンショア、オフショア）分析、産業別（石油＆ガス、水＆廃水処理、鉱業＆浚渫、ユーティリティ＆再生可能エネルギー）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・熱可塑性パイプの世界市場規模：製品タイプ別（熱可塑性複合パイプ（TCP）、強化熱可塑性パイプ（RTP）） ・熱可塑性パイプの世界市場規模：ポリマータイプ別（PE、PP、PVDF、PVC、その他） ・熱可塑性パイプの世界市場規模：用途別（オンショア、オフショア） ・熱可塑性パイプの世界市場規模：産業別（石油＆ガス、水＆廃水処理、鉱業＆浚渫、ユーティリティ＆再生可能エネルギー）...The Thermoplastic Pipe Market has promising growth potential due to the increasing use of engineered thermoplastic materials in manufacturing pipes. The engineering grades of thermoplastic materials, such as polyamide (PA), polyethylene (PE), and polyvinylidene fluoride (PVDF), are gaining increased acceptance in niche oil & gas applications as well. Additional properties such as better chemical, corrosion, and wear resistance, light weight, cost-effectiveness, and acceptable mechanical properties compared with metals have made thermoplastics a viable option for various applications, including water transport and distribution, effluent water disposal, high-pressure water injection, seawater intake and discharge, chemical injections, and transport of oil, gas, water,...
  • 世界の肝炎検査/診断市場予測（～2026）：疾患別、技術別、エンドユーザー別、地域別
    MD6643 / MarketsandMarkets / 2021年11月29日 / マーケッツアンドマーケッツ社は、肝炎検査/診断の世界市場規模が2021年28億ドルから2026年36億ドルまで、年平均4.7％成長すると予測しています。本調査資料では、世界の肝炎検査/診断市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、疾患別（B型肝炎、C型肝炎、その他肝炎）分析、技術別（ELISA、RDT、PCR、INAAT、その他）分析、エンドユーザー別（病院＆診断研究所、血液銀行、その他）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・肝炎検査/診断の世界市場規模：疾患別（B型肝炎、C型肝炎、その他肝炎） ・肝炎検査/診断の世界市場規模：技術別（ELISA、RDT、PCR、INAAT、その他） ・肝炎検査/診断の世界市場規模：エンドユーザー別（病院＆診断研究所、血液銀行、その他） ・肝炎検査/診断の世界市場規模：地域別...“The global hepatitis testing market is projected to reach USD 3.6 billion by 2026 from USD 2.8 billion in 2021, at a CAGR of 4.7% during the forecast period.” The growth of the global hepatitis testing market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis. High cost of nucleic acid tests, lack of mandates for nucleic acid tests in developing countries and unfavorable reimbursement scenarios are expected to restrain hepatitis market growth. Emerging markets, rising technological advancements in molecular diagnostics,...
  • 世界の低侵襲手術用器具市場予測（～2026）：製品別、手術別、エンドユーザー別、地域別
    MD3177 / MarketsandMarkets / 2021年9月28日 / マーケッツアンドマーケッツ社は低侵襲手術用器具の世界市場規模が2021年202億ドルから2026年289億ドルまで、年平均7.4%成長すると予想しています。本調査レポートでは、世界の低侵襲手術用器具市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、製品別（ハンドヘルド型器具、インフレーション装置、手術用スコープ、切断器具、ガイド装置）分析、手術別（胸部外科、胃腸外科、整形外科、婦人科外科、美容整形・減量手術）分析、エンドユーザー別（病院・専門クリニック、外来手術センター（ASCS））分析、地域別分析、競争状況、企業情報などを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・低侵襲手術用器具の世界市場規模：製品別（ハンドヘルド型器具、インフレーション装置、手術用スコープ、切断器具、ガイド装置） ・低侵襲手術用器具の世界市場規模：手術別（胸部外科、胃腸外科、整形外科、婦人科外科、美容整形・減量手術） ・低侵襲手術用器具の世界市場規模：エンドユーザー別（病院・専門クリニック、外来手術センター（ASCS）） ・低侵襲手術用器具の世界市場規模：地域別...“The global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period.” Market growth is driven by factors such as the increasing adoption of advanced robotics in ASCs, the increasing number of surgical procedures worldwide, and the advantages of MIS over open surgical techniques. On the other hand, the high degree of market consolidation among market players and the requirement of high capital investments are the major factors hampering the growth of this market. “The electrosurgical & electrocautery instrumentssegment accounted for...
  • 世界のバイオプロセス容器市場予測（～2026）：種類別、用途別、エンドユーザー別、地域別
    BT6176 / MarketsandMarkets / 2021年9月28日 / マーケッツアンドマーケッツ社はバイオプロセス容器の世界市場規模が2021年29億ドルから2026年96億ドルまで、年平均26.3%成長すると予想しています。本調査レポートでは、世界のバイオプロセス容器市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、種類別（2Dバイオプロセス容器、3Dバイオプロセス容器、その他）分析、用途別（上流プロセス、下流プロセス、プロセス開発）分析、エンドユーザー別（製薬・生物医薬品会社、医薬品開発業務受託機関・医薬品製造受託機関、学術・研究機関）分析、地域別分析、競争状況、企業情報などを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・バイオプロセス容器の世界市場規模：種類別（2Dバイオプロセス容器、3Dバイオプロセス容器、その他） ・バイオプロセス容器の世界市場規模：用途別（上流プロセス、下流プロセス、プロセス開発） ・バイオプロセス容器の世界市場規模：エンドユーザー別（製薬・生物医薬品会社、医薬品開発業務受託機関・医薬品製造受託機関、学術・研究機関） ・バイオプロセス容器の世界市場規模：地域別...“The global bioprocess containers (BPCs) market is projected to grow from USD 2.9 billion in 2021 to USD 9.6 billion by 2026, at a CAGR of 26.3% during the forecast period.” Growth in the bioprocess containers market is mainly driven by factors such as the growing biologics market, affordability and sustainability of single-use bioprocess technologies, and rising biopharmaceutical R&D. Emerging countries and the patent expiry of biologics are expected to offer growth opportunities for players operating in the bioprocess containers market during the forecast period. “By end user segment, the CROs & CMOssegmentaccounted for the fastest-growing segment of thebioprocess containers...
  • 世界の医療における5G市場予測（～2026）：コンポーネント別、用途別、エンドユーザー別
    HIT7990 / MarketsandMarkets / 2021年10月6日 / マーケッツアンドマーケッツ社は医療における5Gの世界市場規模が2021年215百万ドルから2026年3,667百万ドルまで、年平均76.3%成長すると予想しています。本調査レポートでは、世界の医療における5G市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、産業インサイト、コンポーネント別（ハードウェア、サービス、接続性）分析、用途別（コネクテッド医療機器、遠隔患者監視、医療機器用資産追跡、AR/VR、コネクテッド救急車）分析、エンドユーザー別（医療提供者、医療費支払人、その他）分析、地域別分析、競争状況、企業情報などを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・産業インサイト ・医療における5Gの世界市場規模：コンポーネント別（ハードウェア、サービス、接続性） ・医療における5Gの世界市場規模：用途別（コネクテッド医療機器、遠隔患者監視、医療機器用資産追跡、AR/VR、コネクテッド救急車） ・医療における5Gの世界市場規模：エンドユーザー別（医療提供者、医療費支払人、その他）...“5G stands for the fifth generation of mobile communication technology.” With each generation’s new technology and standards, there have been improvements in transmission speed and network capacity. 5G represents a big leap in cellular technology and in healthcare by providing essential levels of connectivity to enable a new health ecosystem, one that can meet the needs of patients and providers accurately, efficiently, cost-effectively, conveniently, and at a substantial scale. This massive network will include billions of low-bitrates and low-energy connected health monitoring devices, remote sensors, and clinical wearables, with 5G providing a backbone infrastructure for IoT. “The 5G in healthcare...
  • 世界の医療用分析試験サービス市場予測（～2026）：種類別、エンドユーザー別
    AST4341 / MarketsandMarkets / 2021年9月30日 / マーケッツアンドマーケッツ社は医療用分析試験サービスの世界市場規模が2021年56億ドルから2026年98億ドルまで、年平均11.9%成長すると予想しています。本調査レポートでは、世界の医療用分析試験サービス市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、種類別（生物分析試験サービス、物理的特性評価サービス、方法開発・妥当性確認サービス、原材料試験サービス、バッチリリース試験サービス）分析、エンドユーザー別（製薬・バイオ医薬品会社、医療機器会社、委託研究機関）分析、地域別分析、競争状況、企業情報などを掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場動向 ・医療用分析試験サービスの世界市場規模：種類別（生物分析試験サービス、物理的特性評価サービス、方法開発・妥当性確認サービス、原材料試験サービス、バッチリリース試験サービス） ・医療用分析試験サービスの世界市場規模：エンドユーザー別（製薬・バイオ医薬品会社、医療機器会社、委託研究機関） ・医療用分析試験サービスの世界市場規模：地域別 ・競争状況...“The healthcare analytical testing services market is projected to reach USD 9.8 billion by 2026 from USD 5.6 billion in 2021, at a CAGR of 11.9%.” Growth in the market is driven by the rising trend of outsourcing of analytical testing by pharmaceutical companies and medical device companies, an increasing number of clinical trials, and the rising acceptance of the QbD approach in pharma research and manufacturing. “The batch-release testing segment is expected to grow at the highest rate, by type, in the healthcare analytical testing services market, in the forecast period.” On the basis of type, the healthcare analytical...
  • 世界の血液スクリーニング市場予測（～2026）：技術別、製品別、エンドユーザー別
    MD3687 / MarketsandMarkets / 2021年12月1日 / マーケッツアンドマーケッツ社は、血液スクリーニングの世界市場規模が2021年25億ドルから2026年38億ドルまで、年平均8.4％成長すると予測しています。本調査資料では、世界の血液スクリーニング市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品＆サービス別（試薬＆キット、器具、ソフトウェア＆サービス）分析、技術別（核酸検査、ELISA、迅速検査、ウエスタンブロットアッセイ、次世代シーケンシング）分析、エンドユーザー別（血液銀行、病院）分析、地域別分析、競争状況、企業情報などの項目を掲載しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・プレミアムインサイト ・市場概要 ・血液スクリーニングの世界市場規模：製品＆サービス別（試薬＆キット、器具、ソフトウェア＆サービス） ・血液スクリーニングの世界市場規模：技術別（核酸検査、ELISA、迅速検査、ウエスタンブロットアッセイ、次世代シーケンシング） ・血液スクリーニングの世界市場規模：エンドユーザー別（血液銀行、病院） ・血液スクリーニングの世界市場規模：地域別...“The global blood screening market is projected to reach USD 3.8 billion by 2026 from USD 2.5 billion in 2021, at a CAGR of 8.4% during the forecast period.” Growth in this market is mainly driven by the growing number of blood donations across the world, the rising prevalence of infectious diseases, and the rising demand for donated blood. “The reagents & kits segment accounted for the highest growth rate in the blood screening market, by product & service, during the forecast period." The blood screening market is segmented into reagents & kits, instruments, and software & services based on...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆